Anti-CD74 Antibody (Milatuzumab)
Catalog No.
F1347
Anti-CD74 Antibody (Milatuzumab)
Featured Products
Milatuzumab (hLL1; MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74 is an integral membrane protein involved in promoting B-cell growth and survival. Milatuzumab causes the generation of free radical oxygen species and loss of mitochondrial membrane potential. Milatuzumab also reduces CD20/CD74 aggregates and cell adhesion, leading to cell death.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.66 kDa
Dry ice
899796-83-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
MEDI-115, hLL1, IMMU-115
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P04233
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CD74 Fc at 2 ug/mL can bind Anti-CD74 Antibody (Milatuzumab)
CD74
Please avoid freeze-thaw cycles.